Explore UAB

The National Institute of Allergy and Infectious Disease recently awarded the UAB Department of Pediatrics contracts totaling $11.5 million under its Broad Agency Announcement mechanism to support two studies to be conducted at UAB and its partner academic sites.
 
The studies will assess treatment of babies born with congenital cytomegalovirus without symptoms, and frequency of neonatal herpes infections in the United States and Peru.
 
Almost one percent of babies born in the United States will have CMV, the largest non-genetic cause of sensory loss and mental disabilities. Ninety percent of these babies will be asymptomatic, or show no visible or laboratory evidence of the disease, at the time of birth. Early detection and close follow-up can lessen the effects of congenital CMV in infants. The new study, supported by a $10 million contract, will explore whether treating babies with four months of an oral drug – valganciclovir –that targets the virus can improve outcomes. 
 
“UAB has been the world leader in studying congenital viral infections for the past 50 years,” said David Kimberlin, M.D., who holds the Sergio Stagno, M.D., Endowed Chair in Pediatric Infectious Disease at UAB. “Our team of researchers and physicians have been instrumental in learning more about CMV and treating the disease. The next step is being able to identify and treat CMV in babies who are asymptomatic at birth.”

A $1.5 million contract will support a study to assess the incidence of neonatal herpes infections in the United States and Peru using large databases in both countries to see how common the infection is. Knowledge gained from these investigations will inform future therapeutic studies aimed to decrease mother-to-infant transmission of herpes simplex virus. A prospective trial also will be conducted in Peru under this contract.

Other UAB researchers involved in these studies that improve the lives of children across the globe include Mary Wyatt Bowers, Penny Jester, Susan Branscum, Sara Davis, Juliette Southworth and Richard Whitley, M.D 

Click here to read more on UAB News.